All you need to know and more about the diagnosis and management of rare mold infections

Martin Hoenigl, Stuart M. Levitz, Audrey N. Schuetz, Sean X. Zhang, Oliver A. Cornely

Research output: Contribution to journalArticlepeer-review


Invasive mold infections caused by molds other than Aspergillus spp. or Mucorales are emerging. The reported prevalences of infection due to these rare fungal pathogens vary among geographic regions, driven by differences in cli-matic conditions, susceptible hosts, and diagnostic capabilities. These rare molds— Fusarium, Lomentospora, andScedosporium species and others—are difficult to detect and often show intrinsic antifungal resistance. Now, international societies of medical mycology and microbiology have joined forces and created the “Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology” (published in Lancet Infect Dis,, with the goal of improving the diagnosis, treatment, prevention, and survival of persons with rare mold infections. The guideline provides cutting-edge guidance for the correct utilization and application of established and new diagnostic and therapeutic options.

Original languageEnglish (US)
Article numbere02920-20
Pages (from-to)1-4
Number of pages4
Issue number1
StatePublished - 2021


  • Basidiomycetes
  • Diagnosis
  • Fusarium
  • Lomentospora
  • Molds
  • Paecilomyces
  • Penicillium
  • Phaeohyphomycosis
  • Rasamsonia
  • Scedosporium
  • Scopulariopsis
  • Treatment

ASJC Scopus subject areas

  • Microbiology
  • Virology


Dive into the research topics of 'All you need to know and more about the diagnosis and management of rare mold infections'. Together they form a unique fingerprint.

Cite this